Literature DB >> 23054954

Spindle cell carcinoma of the larynx with rhabdomyoblastic heterologous element: a rare form of divergent differentiation.

Somak Roy1, Bibianna Purgina, Raja R Seethala.   

Abstract

Spindle cell (sarcomatoid) carcinoma of the larynx is a rare subtype of squamous cell carcinoma that shows a prominent spindle cell component with a mesenchymal phenotype. Heterologous elements may be seen in these spindled areas and usually consist of osteosarcomatous or chondrosarcomatous differentiation. We describe an unusual spindle cell carcinoma of the vocal cord in a 68-year-old male which demonstrated rhabdomyosarcomatous differentiation as confirmed by desmin and myogenin immunoreactivity. Thus rhabdomyosarcomatous differentiation adds to the phenotypic spectrum of spindle cell carcinomas of the larynx and should be considered before invoking a diagnosis of true rhabdomyosarcoma of the larynx.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054954      PMCID: PMC3738762          DOI: 10.1007/s12105-012-0402-3

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  16 in total

1.  Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases.

Authors:  Lester D R Thompson; Jacqueline A Wieneke; Markku Miettinen; Dennis K Heffner
Journal:  Am J Surg Pathol       Date:  2002-02       Impact factor: 6.394

Review 2.  Thymic carcinosarcoma consisting of squamous cell carcinomatous and embryonal rhabdomyosarcomatous components. Report of a case and review of the literature.

Authors:  K Okudela; N Nakamura; J Sano; T Ito; H Kitamura
Journal:  Pathol Res Pract       Date:  2001       Impact factor: 3.250

3.  [Rhabdomyosarcoma and squamous cell cancer of the larynx].

Authors:  N A Antonova; V V Dormakov
Journal:  Vestn Otorinolaringol       Date:  1978 Nov-Dec

Review 4.  Sarcomatoid carcinomas of the upper aerodigestive tracts.

Authors:  J G Batsakis; P Suarez
Journal:  Adv Anat Pathol       Date:  2000-09       Impact factor: 3.875

5.  Pure squamous cell carcinoma of the larynx with cervical nodal metastasis showing rhabdomyosarcomatous differentiation. Clinical, pathologic, and immunohistochemical study of a unique example of divergent differentiation.

Authors:  R L Goldman; N Weidner
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

6.  Mammary carcinosarcoma presenting as rhabdomyosarcoma: an ultrastructural and immunocytochemical study.

Authors:  H B Carstens; J L Cooke
Journal:  Ultrastruct Pathol       Date:  1990 Nov-Dec       Impact factor: 1.094

7.  Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.

Authors:  Toshiharu Matsumoto; Hiroaki Fujii; Atsushi Arakawa; Shigetaka Yamasaki; Hiroshi Sonoue; Kimiaki Hattori; Yoshiaki Kajiyama; Sachiko Hirose; Masahiko Tsurumaru
Journal:  Hum Pathol       Date:  2004-03       Impact factor: 3.466

8.  Spindle cell carcinoma of the oral cavity. A clinicopathologic assessment of fifty-nine cases.

Authors:  G L Ellis; R L Corio
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1980-12

9.  Spindle-cell carcinoma of the upper aerodigestive tract mucosa. An immunohistologic and ultrastructural study of 18 biphasic tumors and comparison with seven monophasic spindle-cell tumors.

Authors:  R J Zarbo; J D Crissman; H Venkat; M A Weiss
Journal:  Am J Surg Pathol       Date:  1986-11       Impact factor: 6.394

10.  True carcinosarcoma of the larynx: a case report.

Authors:  U Srinivasan; G V Talvalkar
Journal:  J Laryngol Otol       Date:  1979-10       Impact factor: 1.469

View more
  9 in total

Review 1.  Role of ancillary techniques in profiling unclassified laryngeal malignancies.

Authors:  H Hellquist; J L Hunt; A Cardesa; A Skalova; P J Slootweg; A Rinaldo; A Ferlito
Journal:  Virchows Arch       Date:  2018-04-06       Impact factor: 4.064

Review 2.  Squamous cell carcinoma of the upper aerodigestive tract: dysplasia and select variants.

Authors:  Bruce M Wenig
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

Review 3.  How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?

Authors:  Fernando López; Michelle D Williams; Antonio Cardesa; Jennifer L Hunt; Primož Strojan; Alessandra Rinaldo; Iain J Nixon; Juan P Rodrigo; Nabil F Saba; William M Mendenhall; Miquel Quer; Carlos Suárez; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-31       Impact factor: 2.503

Review 4.  Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma.

Authors:  Justin A Bishop; Lester D R Thompson; Antonio Cardesa; Leon Barnes; James S Lewis; Asterios Triantafyllou; Henrik Hellquist; Goran Stenman; Jennifer L Hunt; Michelle D Williams; Pieter J Slootweg; Kenneth O Devaney; Douglas R Gnepp; Bruce M Wenig; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck Pathol       Date:  2015-03-11

Review 5.  A review of primary osteosarcoma of the larynx and case report.

Authors:  Esraa Mosalleum; Amir Afrogheh; Sacha Stofberg; Abraham Fourie Bezuidenhout; Johann Schneider; Jos Hille
Journal:  Head Neck Pathol       Date:  2014-06-20

6.  Double primary malignant fibrous histiocytoma and squamous cell carcinoma of the larynx treated with laser laryngeal conservation surgery.

Authors:  P D Karkos; S Dova; S Sotiriou; K Markou; I Kostopoulos
Journal:  Ecancermedicalscience       Date:  2016-04-25

7.  Osteosarcoma of the Larynx: Treatment Outcomes and Patterns of Failure Analysis.

Authors:  Nathan R Bennion; Michael J Baine; Timothy Malouff; Weining Zhen
Journal:  Rare Tumors       Date:  2017-03-24

8.  The Most Common Mistake in Laryngeal Pathology and How to Avoid it.

Authors:  Amin Heidarian; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2021-03-15

9.  Prognostic factors for laryngeal sarcoma and nomogram development for prediction: a retrospective study based on SEER database.

Authors:  Jia Gu; Zhifan Zuo; Lei Sun; Li Li; Ning Zhao
Journal:  Ann Transl Med       Date:  2020-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.